AMBAC FINANCIAL GROUP INC (AMBC)

US0231398845 - Common Stock

14.54  -0.1 (-0.68%)

After market: 14.54 0 (0%)

Fundamental Rating

1

AMBC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. AMBC has a bad profitability rating. Also its financial health evaluation is rather negative. AMBC has a valuation in line with the averages, but it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year AMBC was profitable.
In the past year AMBC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AMBC reported negative net income in multiple years.
In multiple years AMBC reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.11%, AMBC is doing worse than 69.78% of the companies in the same industry.
AMBC has a worse Return On Equity (0.66%) than 69.78% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.76%, AMBC is in line with its industry, outperforming 48.92% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMBC is below the industry average of 4.12%.
Industry RankSector Rank
ROA 0.11%
ROE 0.66%
ROIC 0.76%
ROA(3y)2.15%
ROA(5y)0.3%
ROE(3y)13.29%
ROE(5y)-3.06%
ROIC(3y)2.08%
ROIC(5y)N/A

1.3 Margins

AMBC has a worse Profit Margin (3.46%) than 61.15% of its industry peers.
In the last couple of years the Profit Margin of AMBC has declined.
With an excellent Operating Margin value of 33.08%, AMBC belongs to the best of the industry, outperforming 93.53% of the companies in the same industry.
In the last couple of years the Operating Margin of AMBC has declined.
Industry RankSector Rank
OM 33.08%
PM (TTM) 3.46%
GM N/A
OM growth 3YN/A
OM growth 5Y-19.5%
PM growth 3YN/A
PM growth 5Y-39.3%
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMBC is destroying value.
AMBC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMBC has more shares outstanding
The debt/assets ratio for AMBC has been reduced compared to a year ago.

2.2 Solvency

The Debt to FCF ratio of AMBC is 17.38, which is on the high side as it means it would take AMBC, 17.38 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AMBC (17.38) is worse than 71.94% of its industry peers.
AMBC has a Debt/Equity ratio of 2.55. This is a high value indicating a heavy dependency on external financing.
AMBC has a worse Debt to Equity ratio (2.55) than 94.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF 17.38
Altman-Z N/A
ROIC/WACC0.23
WACC3.32%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

1

3. Growth

3.1 Past

The earnings per share for AMBC have decreased strongly by -82.77% in the last year.
Measured over the past years, AMBC shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.58% on average per year.
Looking at the last year, AMBC shows a decrease in Revenue. The Revenue has decreased by -7.80% in the last year.
The Revenue for AMBC have been decreasing by -12.17% on average. This is quite bad
EPS 1Y (TTM)-82.77%
EPS 3YN/A
EPS 5Y50.58%
EPS growth Q2Q-92.34%
Revenue 1Y (TTM)-7.8%
Revenue growth 3Y18.61%
Revenue growth 5Y-12.17%
Revenue growth Q2Q8.33%

3.2 Future

AMBC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -58.67% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-92.68%
EPS Next 2Y-58.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.63%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.96, which indicates a rather cheap valuation of AMBC.
Based on the Price/Earnings ratio, AMBC is valued a bit cheaper than 71.22% of the companies in the same industry.
AMBC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.25.
The Price/Forward Earnings ratio is 95.03, which means the current valuation is very expensive for AMBC.
AMBC's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AMBC is more expensive than 75.54% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.67, AMBC is valued quite expensively.
Industry RankSector Rank
PE 6.96
Fwd PE 95.03

4.2 Price Multiples

AMBC's Enterprise Value to EBITDA is on the same level as the industry average.
82.01% of the companies in the same industry are more expensive than AMBC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.29
EV/EBITDA 35.08

4.3 Compensation for Growth

A cheap valuation may be justified as AMBC's earnings are expected to decrease with -58.67% in the coming years.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-58.67%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AMBC!.
Industry RankSector Rank
Dividend Yield N/A

AMBAC FINANCIAL GROUP INC

NYSE:AMBC (4/24/2024, 7:04:00 PM)

After market: 14.54 0 (0%)

14.54

-0.1 (-0.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap657.21M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE 95.03
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 0.66%
ROCE
ROIC
ROICexc
ROICexgc
OM 33.08%
PM (TTM) 3.46%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-82.77%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-92.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.8%
Revenue growth 3Y18.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y